{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:47:45Z","timestamp":1776062865547,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>B-lymphocyte proliferative disorder have a certain incidence rate among the elderly. Whether these conditions require treatment is closely related to the presence of concurrent organ damage. This case report details the diagnostic journey and treatment process of a 76-year-old male patient who presented with nephrotic syndrome and acute kidney injury. His condition was further complicated by the presence of monoclonal M proteinemia and the malignant B-lymphocytes in the bone marrow. Through a series of examinations, a diagnosis of podocytopathy with suspected but unconfirmed B-cell lymphoproliferative disorder was established. Treatment involved with CD20 monoclonal antibody (Obinutuzumab). The patient achieved complete remission of proteinuria and normalization of renal function within one month, sustained at one-year follow-up. While the underlying mechanism remains uncertain, whether direct immunomodulation, B-cell clone control or both. This is the first reported case of successful treatment of podocytopathy with concurrent suspected but unconfirmed B-cell lymphoproliferative disorder using Obinutuzumab, offering a new therapeutic way for similar complex medical conditions.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1803073","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:49:19Z","timestamp":1776059359000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Obinutuzumab for the treatment of podocytopathy with concurrent suspected but unconfirmed B-cell lymphoproliferative disorder: a case report and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Yong-Zhe","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-qing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Emergency, The Fourth Affiliated Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei-Ru","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shengjing Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: Report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.3.155","article-title":"Minimal change nephrotic syndrome associated with Hodgkin\u2019s lymphoma","volume":"6","author":"Peces","year":"1991","journal-title":"Nephrology Dialysis Transplantation: Off Publ Eur Dialysis Transplant Association Eur Renal Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/bf00860957","article-title":"Frequently relapsing minimal change nephrotic syndrome with natural killer cell deficiency prior to the overt relapse of Hodgkin\u2019s disease","volume":"9","author":"Mori","year":"1995","journal-title":"Pediatr Nephrol (Berlin Germany)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-024-00596-5","article-title":"Paraneoplastic glomerulonephritis and kidney infiltration by mantle cell lymphoma: A diagnostic challenge","volume":"17","author":"Lerma-Verdejo","year":"2024","journal-title":"J Hematopathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.12.020","article-title":"A diverse spectrum of immune complex- and complement-mediated kidney diseases is associated with mantle cell lymphoma","volume":"7","author":"Andeen","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.ackd.2013.07.004","article-title":"Kidney involvement in leukemia and lymphoma","volume":"21","author":"Luciano","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.12890921","article-title":"Kidney histopathologic spectrum and clinical indicators associated with MGRS","volume":"17","author":"Yong","year":"2022","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2572-23","article-title":"Minimal change nephrotic syndrome secondary to methotrexate-associated Hodgkin lymphoma","volume":"63","author":"Iimori","year":"2024","journal-title":"Internal Med (Tokyo Japan)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.06.021","article-title":"Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease","volume":"50","author":"Aggarwal","year":"2007","journal-title":"Am J Kidney Diseases: Off J Natl Kidney Foundation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-251132","article-title":"Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of C-MIP in Hodgkin-Reed Sternberg cells and podocytes","volume":"115","author":"Audard","year":"2010","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-006-0437-4","article-title":"Concurrent FSGS and Hodgkin\u2019s lymphoma: Case report and literature review on the link between nephrotic glomerulopathies and hematological Malignancies","volume":"10","author":"Mallouk","year":"2006","journal-title":"Clin Exp Nephrol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000000206","article-title":"Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: A retrospective study of 18 cases","volume":"93","author":"Kofman","year":"2014","journal-title":"Medicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.humpath.2010.09.009","article-title":"Patterns of glomerular injury in kidneys infiltrated by lymphoplasmacytic neoplasms","volume":"42","author":"Kowalewska","year":"2011","journal-title":"Hum Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12882-018-1106-z","article-title":"Intravascular lymphoma forming massive aortic tumors complicated with sarcoidosis and focal segmental glomerulosclerosis: A case report and literature review","volume":"19","author":"Oda","year":"2018","journal-title":"BMC Nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31545","article-title":"A rare nephrotic syndrome related to chronic lymphocytic leukemia: Focal segmental glomerulosclerosis","volume":"14","author":"Karakus","year":"2022","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-12-33","article-title":"Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab","volume":"12","author":"Arampatzis","year":"2011","journal-title":"BMC Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-259306","article-title":"Minimal change disease following autologous stem cell transplant for Hodgkin lymphoma","volume":"18","author":"Leung","year":"2025","journal-title":"BMJ Case Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5414\/cn108593","article-title":"Minimal change disease: An unusual presentation of marginal zone MALT lymphoma","volume":"85","author":"Inayat","year":"2016","journal-title":"Clin Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-011-9992-z","article-title":"Minimal change disease associated with MALT lymphoma","volume":"44","author":"Kasmani","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.01.021","article-title":"Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells","volume":"41","author":"Nakayama","year":"2010","journal-title":"Hum Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/j.akdh.2024.10.004","article-title":"Podocytopathies","volume":"32","author":"Navarro-Torres","year":"2025","journal-title":"Adv Kidney Dis Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000533695","article-title":"Review of the role of rituximab in the management of adult minimal change disease and immune-mediated focal and segmental glomerulosclerosis","volume":"3","author":"Aslam","year":"2023","journal-title":"Glomerular Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf039","article-title":"The role of obinutuzumab in rituximab-refractory membranous nephropathy and minimal change disease","volume":"18","author":"Chen","year":"2025","journal-title":"Clin Kidney J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000541972","article-title":"Obinutuzumab may be an effective and safe option for adult minimal change disease and focal segmental glomerulosclerosis patients after multitarget therapy including rituximab","volume":"56","author":"Lin","year":"2025","journal-title":"Am J Nephrol"},{"key":"B25","volume-title":"Drugs and lactation database (Lactmed\u00ae)","year":"2006"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000919","article-title":"Obinutuzumab versus rituximab immunochemotherapy in previously untreated iNHL: Final results from the GALLIUM study","volume":"7","author":"Townsend","year":"2023","journal-title":"HemaSphere"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1803073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:49:21Z","timestamp":1776059361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1803073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2026.1803073"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1803073","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1803073"}}